David Tyronne Howton, Jr

2014

In 2014, David Tyronne Howton, Jr earned a total compensation of $1.7M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 36% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$133,758
Option Awards$1,155,231
Salary$393,407
Other$12,518
Total$1,694,914

Howton received $1.2M in option awards, accounting for 68% of the total pay in 2014.

Howton also received $133.8K in non-equity incentive plan, $393.4K in salary and $12.5K in other compensation.

Rankings

In 2014, David Tyronne Howton, Jr's compensation ranked 5,234th out of 13,032 executives tracked by ExecPay. In other words, Howton earned more than 59.8% of executives.

ClassificationRankingPercentile
All
5,234
out of 13,032
60th
Division
Manufacturing
1,869
out of 4,966
62nd
Major group
Chemicals And Allied Products
628
out of 1,686
63rd
Industry group
Drugs
480
out of 1,365
65th
Industry
Pharmaceutical Preparations
380
out of 1,043
64th
Source: SEC filing on April 27, 2017.

Howton's colleagues

We found five more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2014.

2014

Christopher Garabedian

Sarepta Therapeutics

Chief Executive Officer

2014

Arthur Krieg

Sarepta Therapeutics

Chief Scientific Officer

2014

Sandesh Mahatme

Sarepta Therapeutics

Chief Financial Officer

2014

Edward Kaye

Sarepta Therapeutics

Chief Executive Officer

2014

Jayant Aphale

Sarepta Therapeutics

Senior Vice President, Technical Operations

News

In-depth

You may also like